期刊文献+

甘精胰岛素和门冬胰岛素30对2型糖尿病患者糖脂代谢影响的比较 被引量:10

Effect of Insulin Glargine and Insulin Aspart 30 on Glucose and Lipid Metabolism in Type 2 Diabetes Patients
下载PDF
导出
摘要 目的比较甘精胰岛素和门冬胰岛素30对2型糖尿病患者糖脂代谢的影响。方法选取2015年3月至2015年9月于泰州市人民医院就诊的2型糖尿病患者88例。依据随机数字表法分为对照组和观察组,各44例。对照组患者给予甘精胰岛素0.2 U/kg睡前1次皮下注射进行治疗,观察组给予0.2 U/kg门冬胰岛素30晚餐前1次皮下注射进行治疗。比较两组患者治疗前后血糖[空腹血糖(FPG)、餐后2 h血糖(2 h PBG)、糖化血红蛋白(HbA_(1c))]、血脂[总胆固醇(TC)、三酰甘油(TG)和低密度脂蛋白胆固醇(LDL-C)]水平的变化。结果治疗后,两组患者FPG、2 h PBG、HbA_(1c)均显著低于治疗前,差异有统计学意义(P<0.01)。治疗后观察组和对照组患者FPG[(6.53±0.87)mmol/L比(6.73±0.91)mmol/L]、2 h PBG[(8.34±2.11)mmol/L比(8.51±1.32)mmol/L]、HbA_(1c)[(6.52±0.69)mmol/L比(6.71±0.72)mmol/L]比较差异无统计学意义(P>0.05)。治疗后,两组患者TC、TG和LDL-C均显著低于治疗前(P<0.01)。治疗后,观察组和对照组患者在TC[(4.33±0.79)mmol/L比(4.38±0.88)mmol/L]、TG[(1.34±0.37)比(1.38±0.33)mmol/L]、LDL-C[(2.55±0.54)mmol/L比(2.53±0.57)mmol/L]比较差异无统计学意义(P>0.05)。结论甘精胰岛素和门冬胰岛素30均能有效降低2型糖尿病患者血糖以及血脂水平,值得临床推广。 Objective To compare the effects of insulin glargine and insulin aspart 30 on glucose and lipid metabolism in type 2 diabetes patients. Methods Total of 88 patients with type 2 diabetes treated in Tai Zhou People's Hospital from Jan. 2015 to Jun. 2015 were included as research objects,and divided into a control group and an observation group according to the random number method,44 cases in each group. The control group was given insulin glargine 0. 2 U / kg via subcutaneous injection before bedtime,and the observation group was given 0. 2 U / kg insulin aspart 30 via subcutaneous injection before dinner. The changes of blood glucose [fasting plasma glucose( FPG),2-hour postprandial blood glucoseb( 2 h PBG) and glycated hemoglobin( HbA_(1c)) ]and blood lipid [total cholesterol( TC),triglyceride( TG) and low-density lipoprotein cholesterol( LDL-C) ] levels were compared between the two groups before and after treatment. Results The levels of FPG,2 h PBG and Hb A1 cwere significantly lower than before treatment,the differences were statistically significant( P〈0. 01). There was no significant difference in FPG[( 6. 73 ± 0. 91) mmol / L vs( 6. 53 ± 0. 87) mmol/L],2 h PBG[( 8. 51 ± 1. 32) mmol/L vs( 8. 34 ± 2. 11) mmol/L] and HbA_(1c)[( 6. 71 ± 0. 72) mmol/L vs( 6. 52 ± 0. 69) mmol/L] levels between the two groups after treatment( P〈0. 05). After treatment,the total TC,TG and LDL-C of the two groups were significantly lower than before treatment( P〈0. 01). There was no significant difference in TC[( 4. 33 ± 0. 79) mmol / L vs( 4. 38 ± 0. 88)mmol / L],TG[( 1. 34 ± 0. 37) mmol / L vs( 1. 38 ± 0. 33) mmol / L] and LDL-C[( 2. 55 ± 0. 54) mmol / L vs( 2. 53 ± 0. 57) mmol / L] between the two groups after treatment( P〈0. 05). Conclusion Insulin glargine and insulin aspart 30 can effectively reduce the blood glucose lipid levels in type 2 diabetes patients,thus is worthy of the clinical promotion.
作者 马咏梅
出处 《医学综述》 2016年第22期4559-4561,共3页 Medical Recapitulate
关键词 2型糖尿病 甘精胰岛素 门冬胰岛素30 Type 2 diabetes Insulin glargine Insulin aspart 30
  • 相关文献

参考文献14

二级参考文献139

共引文献250

同被引文献87

引证文献10

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部